COVID-19 Impact on Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size, Status and Forecast 2020-2026

September 2020 | 99 pages | ID: C66A8CEA12E7EN
QYResearch

Abstracts

This report focuses on the global B-Cell Maturation Antigen(BCMA) Targeted Therapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the B-Cell Maturation Antigen(BCMA) Targeted Therapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Transposagen Biopharmaceuticals
• Sutro Biopharma
• Malin Corporation
• Eureka Therapeutics
• firstVentury Equity
• Five Prime Therapeutics
• Credit Suisse Securities
• Dana-Farber Cancer Institute
• Deerfield Partners
• Onyx Pharmaceuticals
• Juno Therapeutics

Market segment by Type, the product can be split into

• Bispecific Antibodies
• Antibody Drug Conjugates
• Chimeric Antigen Receptor T-Cells

Market segment by Application, split into

• Liver Cancer
• Respiratory Cancer
• Brain Cancer
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global B-Cell Maturation Antigen(BCMA) Targeted Therapies status, future forecast, growth opportunity, key market and key players.
• To present the B-Cell Maturation Antigen(BCMA) Targeted Therapies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of B-Cell Maturation Antigen(BCMA) Targeted Therapies are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue
1.4 Market Analysis by Type
  1.4.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Bispecific Antibodies
  1.4.3 Antibody Drug Conjugates
  1.4.4 Chimeric Antigen Receptor T-Cells
1.5 Market by Application
  1.5.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application: 2020 VS 2026
  1.5.2 Liver Cancer
  1.5.3 Respiratory Cancer
  1.5.4 Brain Cancer
  1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry Impact
  1.6.1 How the Covid-19 is Affecting the B-Cell Maturation Antigen(BCMA) Targeted Therapies Industry
    1.6.1.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and B-Cell Maturation Antigen(BCMA) Targeted Therapies Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for B-Cell Maturation Antigen(BCMA) Targeted Therapies Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Perspective (2015-2026)
2.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Growth Trends by Regions
  2.2.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Historic Market Share by Regions (2015-2020)
  2.2.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Growth Strategy
  2.3.6 Primary Interviews with Key B-Cell Maturation Antigen(BCMA) Targeted Therapies Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top B-Cell Maturation Antigen(BCMA) Targeted Therapies Players by Market Size
  3.1.1 Global Top B-Cell Maturation Antigen(BCMA) Targeted Therapies Players by Revenue (2015-2020)
  3.1.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Players (2015-2020)
  3.1.3 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Concentration Ratio
  3.2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue in 2019
3.3 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players Head office and Area Served
3.4 Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Solution and Service
3.5 Date of Enter into B-Cell Maturation Antigen(BCMA) Targeted Therapies Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Historic Market Size by Type (2015-2020)
4.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Type (2021-2026)

5 B-CELL MATURATION ANTIGEN(BCMA) TARGETED THERAPIES BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)
5.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2020)
6.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in North America (2019-2020)
6.3 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)
6.4 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2020)
7.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in Europe (2019-2020)
7.3 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)
7.4 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

8 CHINA

8.1 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2020)
8.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in China (2019-2020)
8.3 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)
8.4 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2020)
9.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in Japan (2019-2020)
9.3 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)
9.4 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2020)
10.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)
10.4 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

11 INDIA

11.1 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2020)
11.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in India (2019-2020)
11.3 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)
11.4 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (2015-2020)
12.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Players in Central & South America (2019-2020)
12.3 Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020)
12.4 Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Transposagen Biopharmaceuticals
  13.1.1 Transposagen Biopharmaceuticals Company Details
  13.1.2 Transposagen Biopharmaceuticals Business Overview and Its Total Revenue
  13.1.3 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
  13.1.4 Transposagen Biopharmaceuticals Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020))
  13.1.5 Transposagen Biopharmaceuticals Recent Development
13.2 Sutro Biopharma
  13.2.1 Sutro Biopharma Company Details
  13.2.2 Sutro Biopharma Business Overview and Its Total Revenue
  13.2.3 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
  13.2.4 Sutro Biopharma Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
  13.2.5 Sutro Biopharma Recent Development
13.3 Malin Corporation
  13.3.1 Malin Corporation Company Details
  13.3.2 Malin Corporation Business Overview and Its Total Revenue
  13.3.3 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
  13.3.4 Malin Corporation Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
  13.3.5 Malin Corporation Recent Development
13.4 Eureka Therapeutics
  13.4.1 Eureka Therapeutics Company Details
  13.4.2 Eureka Therapeutics Business Overview and Its Total Revenue
  13.4.3 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
  13.4.4 Eureka Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
  13.4.5 Eureka Therapeutics Recent Development
13.5 firstVentury Equity
  13.5.1 firstVentury Equity Company Details
  13.5.2 firstVentury Equity Business Overview and Its Total Revenue
  13.5.3 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
  13.5.4 firstVentury Equity Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
  13.5.5 firstVentury Equity Recent Development
13.6 Five Prime Therapeutics
  13.6.1 Five Prime Therapeutics Company Details
  13.6.2 Five Prime Therapeutics Business Overview and Its Total Revenue
  13.6.3 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
  13.6.4 Five Prime Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
  13.6.5 Five Prime Therapeutics Recent Development
13.7 Credit Suisse Securities
  13.7.1 Credit Suisse Securities Company Details
  13.7.2 Credit Suisse Securities Business Overview and Its Total Revenue
  13.7.3 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
  13.7.4 Credit Suisse Securities Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
  13.7.5 Credit Suisse Securities Recent Development
13.8 Dana-Farber Cancer Institute
  13.8.1 Dana-Farber Cancer Institute Company Details
  13.8.2 Dana-Farber Cancer Institute Business Overview and Its Total Revenue
  13.8.3 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
  13.8.4 Dana-Farber Cancer Institute Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
  13.8.5 Dana-Farber Cancer Institute Recent Development
13.9 Deerfield Partners
  13.9.1 Deerfield Partners Company Details
  13.9.2 Deerfield Partners Business Overview and Its Total Revenue
  13.9.3 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
  13.9.4 Deerfield Partners Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
  13.9.5 Deerfield Partners Recent Development
13.10 Onyx Pharmaceuticals
  13.10.1 Onyx Pharmaceuticals Company Details
  13.10.2 Onyx Pharmaceuticals Business Overview and Its Total Revenue
  13.10.3 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
  13.10.4 Onyx Pharmaceuticals Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
  13.10.5 Onyx Pharmaceuticals Recent Development
13.11 Juno Therapeutics
  10.11.1 Juno Therapeutics Company Details
  10.11.2 Juno Therapeutics Business Overview and Its Total Revenue
  10.11.3 Juno Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Introduction
  10.11.4 Juno Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
  10.11.5 Juno Therapeutics Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Market Segments
Table 2. Key Players Covered: Ranking by B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue
Table 3. Ranking of Global Top B-Cell Maturation Antigen(BCMA) Targeted Therapies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Bispecific Antibodies
Table 6. Key Players of Antibody Drug Conjugates
Table 7. Key Players of Chimeric Antigen Receptor T-Cells
Table 8. COVID-19 Impact Global Market: (Four B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for B-Cell Maturation Antigen(BCMA) Targeted Therapies Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for B-Cell Maturation Antigen(BCMA) Targeted Therapies Players to Combat Covid-19 Impact
Table 13. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Regions (2015-2020)
Table 17. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Growth Strategy
Table 23. Main Points Interviewed from Key B-Cell Maturation Antigen(BCMA) Targeted Therapies Players
Table 24. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue by Players (2015-2020) (Million US$)
Table 25. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Players (2015-2020)
Table 26. Global Top B-Cell Maturation Antigen(BCMA) Targeted Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies as of 2019)
Table 27. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Solution and Service
Table 30. Date of Enter into B-Cell Maturation Antigen(BCMA) Targeted Therapies Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) (Million US$)
Table 33. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Share by Type (2015-2020)
Table 34. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Market Share by Type (2021-2026)
Table 35. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Share by Application (2015-2020)
Table 36. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) (Million US$)
Table 37. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size Share by Application (2021-2026)
Table 38. North America Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (2019-2020) (Million US$)
Table 39. North America Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share (2019-2020)
Table 40. North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) (Million US$)
Table 41. North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type (2015-2020)
Table 42. North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) (Million US$)
Table 43. North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2015-2020)
Table 44. Europe Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share (2019-2020)
Table 46. Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) (Million US$)
Table 47. Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type (2015-2020)
Table 48. Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) (Million US$)
Table 49. Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2015-2020)
Table 50. China Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (2019-2020) (Million US$)
Table 51. China Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share (2019-2020)
Table 52. China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) (Million US$)
Table 53. China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type (2015-2020)
Table 54. China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) (Million US$)
Table 55. China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2015-2020)
Table 56. Japan Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share (2019-2020)
Table 58. Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) (Million US$)
Table 59. Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type (2015-2020)
Table 60. Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) (Million US$)
Table 61. Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share (2019-2020)
Table 64. Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type (2015-2020)
Table 66. Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2015-2020)
Table 68. India Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (2019-2020) (Million US$)
Table 69. India Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share (2019-2020)
Table 70. India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) (Million US$)
Table 71. India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type (2015-2020)
Table 72. India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) (Million US$)
Table 73. India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2015-2020)
Table 74. Central & South America Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share (2019-2020)
Table 76. Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type (2015-2020)
Table 78. Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application (2015-2020)
Table 80. Transposagen Biopharmaceuticals Company Details
Table 81. Transposagen Biopharmaceuticals Business Overview
Table 82. Transposagen Biopharmaceuticals Product
Table 83. Transposagen Biopharmaceuticals Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) (Million US$)
Table 84. Transposagen Biopharmaceuticals Recent Development
Table 85. Sutro Biopharma Company Details
Table 86. Sutro Biopharma Business Overview
Table 87. Sutro Biopharma Product
Table 88. Sutro Biopharma Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) (Million US$)
Table 89. Sutro Biopharma Recent Development
Table 90. Malin Corporation Company Details
Table 91. Malin Corporation Business Overview
Table 92. Malin Corporation Product
Table 93. Malin Corporation Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) (Million US$)
Table 94. Malin Corporation Recent Development
Table 95. Eureka Therapeutics Company Details
Table 96. Eureka Therapeutics Business Overview
Table 97. Eureka Therapeutics Product
Table 98. Eureka Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) (Million US$)
Table 99. Eureka Therapeutics Recent Development
Table 100. firstVentury Equity Company Details
Table 101. firstVentury Equity Business Overview
Table 102. firstVentury Equity Product
Table 103. firstVentury Equity Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) (Million US$)
Table 104. firstVentury Equity Recent Development
Table 105. Five Prime Therapeutics Company Details
Table 106. Five Prime Therapeutics Business Overview
Table 107. Five Prime Therapeutics Product
Table 108. Five Prime Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) (Million US$)
Table 109. Five Prime Therapeutics Recent Development
Table 110. Credit Suisse Securities Company Details
Table 111. Credit Suisse Securities Business Overview
Table 112. Credit Suisse Securities Product
Table 113. Credit Suisse Securities Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) (Million US$)
Table 114. Credit Suisse Securities Recent Development
Table 115. Dana-Farber Cancer Institute Business Overview
Table 116. Dana-Farber Cancer Institute Product
Table 117. Dana-Farber Cancer Institute Company Details
Table 118. Dana-Farber Cancer Institute Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) (Million US$)
Table 119. Dana-Farber Cancer Institute Recent Development
Table 120. Deerfield Partners Company Details
Table 121. Deerfield Partners Business Overview
Table 122. Deerfield Partners Product
Table 123. Deerfield Partners Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) (Million US$)
Table 124. Deerfield Partners Recent Development
Table 125. Onyx Pharmaceuticals Company Details
Table 126. Onyx Pharmaceuticals Business Overview
Table 127. Onyx Pharmaceuticals Product
Table 128. Onyx Pharmaceuticals Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) (Million US$)
Table 129. Onyx Pharmaceuticals Recent Development
Table 130. Juno Therapeutics Company Details
Table 131. Juno Therapeutics Business Overview
Table 132. Juno Therapeutics Product
Table 133. Juno Therapeutics Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020) (Million US$)
Table 134. Juno Therapeutics Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Type: 2020 VS 2026
Figure 2. Bispecific Antibodies Features
Figure 3. Antibody Drug Conjugates Features
Figure 4. Chimeric Antigen Receptor T-Cells Features
Figure 5. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Application: 2020 VS 2026
Figure 6. Liver Cancer Case Studies
Figure 7. Respiratory Cancer Case Studies
Figure 8. Brain Cancer Case Studies
Figure 9. Others Case Studies
Figure 10. B-Cell Maturation Antigen(BCMA) Targeted Therapies Report Years Considered
Figure 11. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Regions: 2020 VS 2026
Figure 13. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share by Players in 2019
Figure 16. Global Top B-Cell Maturation Antigen(BCMA) Targeted Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in B-Cell Maturation Antigen(BCMA) Targeted Therapies as of 2019
Figure 17. The Top 10 and 5 Players Market Share by B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue in 2019
Figure 18. North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Transposagen Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Transposagen Biopharmaceuticals Revenue Growth Rate in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
Figure 27. Sutro Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Sutro Biopharma Revenue Growth Rate in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
Figure 29. Malin Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Malin Corporation Revenue Growth Rate in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
Figure 31. Eureka Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Eureka Therapeutics Revenue Growth Rate in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
Figure 33. firstVentury Equity Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. firstVentury Equity Revenue Growth Rate in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
Figure 35. Five Prime Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Five Prime Therapeutics Revenue Growth Rate in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
Figure 37. Credit Suisse Securities Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Credit Suisse Securities Revenue Growth Rate in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
Figure 39. Dana-Farber Cancer Institute Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Dana-Farber Cancer Institute Revenue Growth Rate in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
Figure 41. Deerfield Partners Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Deerfield Partners Revenue Growth Rate in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
Figure 43. Onyx Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Onyx Pharmaceuticals Revenue Growth Rate in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
Figure 45. Juno Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Juno Therapeutics Revenue Growth Rate in B-Cell Maturation Antigen(BCMA) Targeted Therapies Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed